• Spermosens called SEK 4.85 million under its previously announced capital facility via a directed issue of units to participating investors.
• Each unit comprises one share priced at a 15% discount to 10-day VWAP, subject to a floor at the shares’ quota value.
• Each unit also includes one warrant issued free, exercisable for one new share at SEK 0.03 with a three-year term.
• The board plans to set the VWAP measurement period over the next 10 trading days, then decide on the directed issue within one week.
• A separate directed issue to Ulrik Spork and Tore Duvold will be put to an extraordinary general meeting under Sweden’s Leo Rules.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Spermosens AB published the original content used to generate this news brief via Cision (Ref. ID: 20260708:BIT:6609:0) on July 21, 2026, and is solely responsible for the information contained therein.